Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| 1 |
Alibaba
BABA
|
+$2.59B |
| 2 |
STER
Sterling Check Corp. Common Stock
STER
|
+$1.56B |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.31B |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.27B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$1.04B |
Top Sells
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$902M |
| 2 |
Walmart
WMT
|
+$484M |
| 3 |
Willis Towers Watson
WTW
|
+$483M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$436M |
| 5 |
Salesforce
CRM
|
+$374M |
Sector Composition
| 1 | Technology | 19% |
| 2 | Consumer Discretionary | 11.51% |
| 3 | Financials | 10.06% |
| 4 | Healthcare | 9.39% |
| 5 | Communication Services | 7.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2626
iShares Global Consumer Staples ETF
KXI
$861M
| $5.91M | ﹤0.01% |
98,469
-4,878
| -5% | -$293K |
|
|
AILE
2627
DELISTED
iLearningEngines, Inc. Common Stock
AILE
| $5.9M | ﹤0.01% |
609,458
-1,600
| -0.3% | -$15.5K |
|
|
LGAC
2628
DELISTED
Lazard Growth Acquisition Corp. I Ordinary Shares
LGAC
| $5.9M | ﹤0.01% |
605,950
-4,000
| -0.7% | -$38.9K |
|
|
HCAR
2629
DELISTED
Healthcare Services Acquisition Corporation Class A Common Stock
HCAR
| $5.89M | ﹤0.01% |
604,386
-62,467
| -9% | -$609K |
|
2630
Nelnet
NNI
$4.53B
| $5.89M | ﹤0.01% |
74,291
+28,666
| +63% | +$2.27M |
|
2631
Mesa Laboratories
MLAB
$358M
| $5.88M | ﹤0.01% |
19,457
+13,622
| +233% | +$4.12M |
|
2632
Maravai LifeSciences
MRVI
$407M
| $5.88M | ﹤0.01% |
119,860
-17,168
| -13% | -$843K |
|
2633
Heartland Express
HTLD
$650M
| $5.86M | ﹤0.01% |
365,691
+86,256
| +31% | +$1.38M |
|
|
OEPW
2634
DELISTED
One Equity Partners Open Water I Corp. Class A Common Stock
OEPW
| $5.84M | ﹤0.01% |
600,416
-72
| -0% | -$701 |
|
2635
OFG Bancorp
OFG
$1.95B
| $5.84M | ﹤0.01% |
231,580
-20,022
| -8% | -$505K |
|
2636
Green Plains
GPRE
$630M
| $5.83M | ﹤0.01% |
178,561
-1,465,151
| -89% | -$47.8M |
|
2637
Sandstorm Gold
SAND
$3.44B
| $5.83M | ﹤0.01% |
1,011,460
+436,343
| +76% | +$2.51M |
|
2638
Bank of N.T. Butterfield & Son
NTB
$1.87B
| $5.82M | ﹤0.01% |
163,792
+45,967
| +39% | +$1.63M |
|
|
APEN
2639
DELISTED
Apollo Endosurgery, Inc.
APEN
| $5.82M | ﹤0.01% |
641,971
+4,716
| +0.7% | +$42.7K |
|
2640
Enanta Pharmaceuticals
ENTA
$161M
| $5.81M | ﹤0.01% |
102,332
-41,099
| -29% | -$2.34M |
|
2641
AtriCure
ATRC
$1.74B
| $5.8M | ﹤0.01% |
83,382
+18,762
| +29% | +$1.31M |
|
|
MGI
2642
DELISTED
MoneyGram International, Inc. New
MGI
| $5.8M | ﹤0.01% |
722,982
-1,561,030
| -68% | -$12.5M |
|
2643
Clear Channel Outdoor Holdings
CCO
$691M
| $5.8M | ﹤0.01% |
2,138,457
+738,013
| +53% | +$2M |
|
2644
CEVA Inc
CEVA
$593M
| $5.79M | ﹤0.01% |
135,743
-20,733
| -13% | -$885K |
|
2645
Direxion Daily Financial Bull 3x Shares
FAS
$2.8B
| $5.78M | ﹤0.01% |
+50,000
| New | +$5.78M |
|
|
CIO
2646
City Office REIT
CIO
$281M
| $5.78M | ﹤0.01% |
323,581
-589,789
| -65% | -$10.5M |
|
2647
Photronics
PLAB
$1.38B
| $5.77M | ﹤0.01% |
423,251
+138,461
| +49% | +$1.89M |
|
|
VCRA
2648
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $5.75M | ﹤0.01% |
125,753
+66,730
| +113% | +$3.05M |
|
|
HUYA
2649
Huya Inc
HUYA
$787M
| $5.75M | ﹤0.01% |
689,329
+521,504
| +311% | +$4.35M |
|
2650
Karyopharm Therapeutics
KPTI
$52.7M
| $5.74M | ﹤0.01% |
65,692
-1,356
| -2% | -$118K |
|